Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-512-0 | CAS number: 65140-91-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1985
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Comparable to guideline study under GLP-like quality control with QAU statement provided. Replacement of the first intradermal injection by epicutaneous treatment due to insolubility of the test substance in stadard vehicles. No Purity of test substance available.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- (adopted 1981)
- Deviations:
- yes
- Remarks:
- due to the insolubility of the test substances in standard vehicles, the test substance was applied epicutaneously at the first induction treatment.
- Principles of method if other than guideline:
- The modification of the GPMT is not mentioned in the OECD guideline 406, but is scientifically based and published (Maurer Th and Hess R (1989) The maximization test for skin sensitization potential- updating the standard protocol and validation of a modified protocol. Fd. Chem. Toxic. (27) 12, 807-811)
- GLP compliance:
- no
- Remarks:
- but QAU statement included
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- Calcium diethyl bis[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]phosphonate]
- EC Number:
- 265-512-0
- EC Name:
- Calcium diethyl bis[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]phosphonate]
- Cas Number:
- 65140-91-2
- Molecular formula:
- C17 H29 O4 P. 1/2Ca
- IUPAC Name:
- calcium diethyl bis[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]phosphonate]
- Details on test material:
- - Physical state: solid
- Storage condition of test material: room temperature
- Purity: commercial grade
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Pirbright-White
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: ca. 10 weeks
- Weight at study initiation: 304-427 g
- Housing: single housing in Makrolon cages (Type 3)
- Diet: Standard guinea pig pellets, NAFAG No. 846, Gossau SG, supplemented with carrots, ad libitum
- Water: ad libitum
- Acclimation period: 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21+/-2
- Humidity (%): 50+/-10
- Photoperiod: 12 hrs dark / 12 hrs light
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- First induction: 30% in vaseline (0.4 g per patch)
Second induction: 30% in vaseline (0.4 g per patch)
Challenge: 0.3% in vaseline (0.2 g per patch)
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- First induction: 30% in vaseline (0.4 g per patch)
Second induction: 30% in vaseline (0.4 g per patch)
Challenge: 0.3% in vaseline (0.2 g per patch)
- No. of animals per dose:
- 10 males and 10 females
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: two
- Test groups: 0.1 ml of a freshly prepared adjuvant saline mixture was injected intracutaneously at 4 sites on the animal's neck. The test compound was applied on filter patches ( 2 x 4 cm) to the epidermis over the injection sites for 24 hours under an occlusive dressing. Dose of application: 30%, 0.4 g paste in vaseline. One week later the test compound was applied occlusively in the same way as during the first week on induction for 48 hours. Dose of application: 0.4 g paste in vaseline
- Control group: A control group was treated with adjuvant and the vehicle during the induction period.
- Concentrations: 30%
- Site: neck
B. CHALLENGE EXPOSURE
- No. of exposures: single exposure
- Day of challenge: 14 days after end of second induction period
- Exposure period: 24 h, epidermal, occlusive
- Test groups: After a rest period of 14 days the compound and the vehicle was applied on filter paper patches ( 2 x 2 cm) to the untreated contralateral flanks of the animals for 24 hours epidermal occlusively.
- Control group: treated with the vehicle as well as with the test compound to control the maximal subirritant concentration of the test compound in adjuvant treated animals.
- Site: contralateral flanks
- Concentrations: 0.3% (ca. 0.2 g per patch)
- Evaluation: 24 and 48 h after removing the dressing - Challenge controls:
- A control group of 20 animals (10 m/10 f) was treated with adjuvant and the vehicle during the induction period. During the challenge period, the group was treated with the vehicle as well as with the test item to check the maximum subirritant concentration of the test article in adjuvant treated animals.
- Positive control substance(s):
- no
Results and discussion
- Positive control results:
- The sensitivity of the strain is checked every 6 months with p-phenylendiamine. No data were given in the test report.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0.3%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0.3%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.3%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.3%. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0.3%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0.3%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.3%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.3%. No with. + reactions: 0.0. Total no. in groups: 20.0.
Any other information on results incl. tables
The test substance at the concentration of 0.3% in vaseline, did neither induce edema nor erythema reactions after epidermal challenge application.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Based on the results of this study and under the test conditions chosen, the test substance is not considered to be a skin sensitizer.
- Executive summary:
In a modified guinea pig maximization test, 10 male and 10 female animals were first induced and then challenged with the test article to investigate its sensitization potential. A modified procedure from the maximization test, as it is recommended in the OECD guidelines 1981 and in the EEC directive 79/831, was selected on account of its suitability for final formulations or for compounds which are not injectable on account of their insolubility in standard vehicles. Instead of an intradermal injection, the test substance was applied epicutaneously during induction. Induction was a two-stage operation: First, am mixture of adjuvant/saline was injected intracutaneously at four sites on the animals’ neck. The test compound (30% in vaseline) was applied to the epidermis over the injection sites for 24 hours under an occlusive dressing. One week later, the test compound was applied occlusively in the same way as during the first week on induction for 48 hours. After a rest period of 14 days the compound and the vehicle was applied on filter paper patches ( 2 x 2 cm) to the untreated contralateral flanks of the animals for 24 hours epidermal occlusively. Twenty four and 48 hours after removing the dressings the challenge reactions were graded according to the Draize scoring scale. A control group (10 m/10 f) was treated with adjuvant and the vehicle during the induction period. During the challenge period the group was treated with the vehicle as well as with the test compound to control the maximal subirritant concentration of the test compound in adjuvant treated animals. No animal of the test group was sensitized by the test substance, all skin reactions at 24 and 48 hour time points were scored 0. Therefore, under the experimental conditions of this study, the test material is non-sensitizing when topically applied to albino guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.